益方生物-U
(688382)
| 流通市值：106.82亿 | | | 总市值：106.82亿 |
| 流通股本：5.80亿 | | | 总股本：5.80亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 53,319,157.26 | 42,542,363.91 | 37,289,660.96 | 30,893,466.9 |
| 营业总成本 | 197,393,419.4 | 85,655,003.18 | 353,562,227.75 | 205,986,997.9 |
| 其他经营收益 | | | | |
| 营业利润 | -137,282,091.1 | -44,259,262.21 | -316,623,274.68 | -181,245,999.11 |
| 利润总额 | -137,282,091.1 | -44,259,262.21 | -316,626,274.68 | -181,245,999.11 |
| 净利润 | -137,081,503.6 | -44,367,216.91 | -316,865,800.68 | -181,385,152.31 |
| 每股收益 | | | | |
| 其他综合收益 | 501,693.7 | -1,203,735.61 | -506,075.02 | -559,520.77 |
| 综合收益总额 | -136,579,809.9 | -45,570,952.52 | -317,371,875.7 | -181,944,673.08 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,461,404,666.01 | 1,546,402,911.91 | 1,651,236,597.25 | 1,714,499,837.05 |
| 非流动资产: | | | | |
| 非流动资产合计 | 60,787,151.83 | 54,739,754 | 52,609,995.99 | 49,967,399.71 |
| 资产总计 | 1,522,191,817.84 | 1,601,142,665.91 | 1,703,846,593.24 | 1,764,467,236.76 |
| 流动负债: | | | | |
| 流动负债合计 | 95,557,266.65 | 89,079,512.3 | 148,902,915.08 | 80,564,360.53 |
| 非流动负债: | | | | |
| 非流动负债合计 | 15,509,435.88 | 16,253,537.1 | 18,827,568.71 | 18,478,349.67 |
| 负债合计 | 111,066,702.53 | 105,333,049.4 | 167,730,483.79 | 99,042,710.2 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,411,125,115.31 | 1,495,809,616.51 | 1,536,116,109.45 | 1,665,424,526.56 |
| 股东权益合计 | 1,411,125,115.31 | 1,495,809,616.51 | 1,536,116,109.45 | 1,665,424,526.56 |
| 负债和股东权益合计 | 1,522,191,817.84 | 1,601,142,665.91 | 1,703,846,593.24 | 1,764,467,236.76 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 65,650,911.88 | 4,522,773.35 | 125,882,277.85 | 35,576,435.95 |
| 经营活动现金流出小计 | 253,593,913.89 | 147,151,634.04 | 281,327,102.83 | 195,632,819.88 |
| 经营活动产生的现金流量净额 | -187,943,002.01 | -142,628,860.69 | -155,444,824.98 | -160,056,383.93 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,196,699,949.18 | 567,779,525.1 | 1,281,109,699.59 | 950,395,807.66 |
| 投资活动现金流出小计 | 1,072,794,161.85 | 749,221,819.25 | 1,307,437,951.94 | 1,032,758,133.13 |
| 投资活动产生的现金流量净额 | 123,905,787.33 | -181,442,294.15 | -26,328,252.35 | -82,362,325.47 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 5,409,281.55 | - | 6,974,337.6 | 6,974,337.6 |
| 筹资活动现金流出小计 | 23,020,418.26 | 13,128,416.78 | 13,194,666.38 | 5,843,945.24 |
| 筹资活动产生的现金流量净额 | -17,611,136.71 | -13,128,416.78 | -6,220,328.78 | 1,130,392.36 |
| 汇率变动对现金及现金等价物的影响 | -222,068.51 | -1,211,496.6 | -2,833,438.79 | -2,492,032.99 |
| 现金及现金等价物净增加额 | -81,870,419.9 | -338,411,068.22 | -190,826,844.9 | -243,780,350.03 |
| 期末现金及现金等价物余额 | 641,249,303.39 | 384,708,655.07 | 723,119,723.29 | 670,166,218.16 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -81,870,419.9 | - | -190,826,844.9 | - |
最新报告期：2026-09-01| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东方证券 | 伍云飞 | -0.54 | -0.47 | -0.38 | 2026-09-01 |